← Leaderboards
Michael D Lairmore
Ohio State University
$5,085,750
Attributed
$5,085,750
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$21,549,077 · 9
By mechanism
P01$18,098,956 · 3
T32$1,576,057 · 2
R01$1,552,872 · 2
K02$200,232 · 1
R03$120,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Patrick Lee Green$10,720,230
- Louis M Mansky$15,115,622
- Kathleen A Boris-Lawrie$4,718,846
- Amanda Robinson Panfil$689,288
Others in their field
Top investigators on “Cell Transformation”
- Hugh Rosen · Scripps Research Institute$67,361,551
- Mary L. Disis · University Of Washington$62,859,950
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
Research focus
Cell TransformationVirus ReplicationRetroviridaeVirus Infection MechanismHuman T Cell Lymphotropic Virus Type 1Open Reading FramesGenetic TranscriptionTranscription FactorLymphocyteLymphocyte ActivationGene MutationVirus ProteinModel Design /DevelopmentMessenger RnaDisease /Disorder ModelAcetylationVirus GeneticsSiteGleanAffectCollaborationsBinding (Molecular Function)Human T-Lymphotropic Virus 1Base
Grant awards (41)
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair$178,572
P01 · FY2012 · CA · contact PI
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration$153,893
P01 · FY2012 · CA · contact PI
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair$182,977
P01 · FY2011 · CA · contact PI
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration$156,685
P01 · FY2011 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$2,158,486
P01 · FY2010 · CA · contact PI
Mouse Pathobiology: Models of Human Disease$421,631
T32 · FY2010 · RR · contact PI
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair$191,631
P01 · FY2010 · CA · contact PI
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration$162,294
P01 · FY2010 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$2,124,046
P01 · FY2009 · CA · contact PI
Mouse Pathobiology: Models of Human Disease$289,965
T32 · FY2009 · RR · contact PI
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair$190,882
P01 · FY2009 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$165,127
P01 · FY2009 · CA · contact PI
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration$159,867
P01 · FY2009 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$2,094,373
P01 · FY2008 · CA · contact PI
Mouse Pathobiology: Models of Human Disease$415,345
T32 · FY2008 · RR · contact PI
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair$143,249
P01 · FY2008 · CA · contact PI
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration$115,579
P01 · FY2008 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation/Disease$1,980,571
P01 · FY2007 · CA · contact PI
Mouse Pathobiology: Models of Human Disease$296,704
T32 · FY2007 · RR · contact PI
Retrovirus Models of Lymphocyte Transformation/Disease$54,337
P01 · FY2007 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation/Disease$1,980,307
P01 · FY2006 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation/Disease$50,857
P01 · FY2006 · CA · contact PI
Retrovirus Models of Lymphocyte Transformation/Disease$1,968,912
P01 · FY2005 · CA
Retrovirus Models of Lymphocyte Transformation and Disease- Competing Supplement$49,549
P01 · FY2005 · CA
RESEARCH TRAINING FOR VETERINARY STUDENTS$877
T32 · FY2005 · RR
Retrovirus Models of Lymphocyte Transformation/Disease$1,911,560
P01 · FY2004 · CA
RESEARCH TRAINING FOR VETERINARY STUDENTS$76,636
T32 · FY2004 · RR
Retrovirus Models of Lymphocyte Transformation/Disease$48,280
P01 · FY2004 · CA
Studies of p30 II and p13 II in HTLV-1 Infection$40,320
R03 · FY2004 · TW
Retrovirus Models of Lymphocyte Transformation/Disease$1,876,922
P01 · FY2003 · CA
ANIMAL MODELS OF MOLECULAR PATHOGENSIS OF HTLV-1$324,840
R01 · FY2003 · RR
RESEARCH TRAINING FOR VETERINARY STUDENTS$74,899
T32 · FY2003 · RR
Mechanism of p12I and p30II in HTLV1 Infection$47,011
R01 · FY2003 · CA
Studies of p30 II and p13 II in HTLV-1 Infection$40,320
R03 · FY2003 · TW
ANIMAL MODELS OF MOLECULAR PATHOGENSIS OF HTLV-1$315,378
R01 · FY2002 · RR
Mechanism of p12I and p30II in HTLV1 Infection$262,179
R01 · FY2002 · CA
Studies of p30 II and p13 II in HTLV-1 Infection$40,320
R03 · FY2002 · TW
ANIMAL MODELS OF MOLECULAR PATHOGENSIS OF HTLV-1$306,191
R01 · FY2001 · RR
CRE-MEDIATED TRANSCRIPTION IN PRIMARY T LYMPHOCYTES$100,116
K02 · FY2001 · AI
ANIMAL MODELS OF MOLECULAR PATHOGENSIS OF HTLV-1$297,273
R01 · FY2000 · RR
CRE-MEDIATED TRANSCRIPTION IN PRIMARY T LYMPHOCYTES$100,116
K02 · FY2000 · AI